Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P41
Within normal range
vs 3Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -18.21% |
| Q3 2025 | 9.14% |
| Q2 2025 | -3.40% |
| Q1 2025 | -25.30% |
| Q4 2024 | -15.59% |
| Q3 2024 | -6.23% |
| Q2 2024 | 5.35% |
| Q1 2024 | -257.18% |
| Q4 2023 | 164.88% |
| Q3 2023 | -122.71% |
| Q2 2023 | 61.88% |
| Q1 2023 | -27.66% |
| Q4 2022 | 18.04% |
| Q3 2022 | -40.69% |
| Q2 2022 | 22.79% |
| Q1 2022 | -37.91% |
| Q4 2021 | -3.13% |
| Q3 2021 | 4.96% |
| Q2 2021 | -491.59% |
| Q1 2021 | 139.32% |
| Q4 2020 | -233.53% |
| Q3 2020 | 57.44% |
| Q2 2020 | -135.22% |
| Q1 2020 | 421.40% |
| Q4 2019 | -135.05% |
| Q3 2019 | 372.63% |
| Q2 2019 | -37.79% |
| Q1 2019 | 0.00% |